AVO is focused on delivering a more affordable, novel proton-based radiotherapy system, based on a technology originally developed and tested at the world renowned CERN. Management has proven its capability of following tight timelines and remains on schedule to deliver the first LIGHT system in 2017. Progress on Planning Permission for its Harley Street site remains very much on track for 2016, while planning for the Pebble Mill site is taking shape, and financing for this development is now in place. Having entered in an industrialisation agreement with Thales, AVO announced the agreement for a £24m loan from Metric Capital
11 Aug 2016
Delivering on plan
Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
Delivering on plan
Advanced Oncotherapy Plc (AVO:LON) | 1.9 0 0.0% | Mkt Cap: 10.4m
- Published:
11 Aug 2016 -
Author:
Martin Hall -
Pages:
12
AVO is focused on delivering a more affordable, novel proton-based radiotherapy system, based on a technology originally developed and tested at the world renowned CERN. Management has proven its capability of following tight timelines and remains on schedule to deliver the first LIGHT system in 2017. Progress on Planning Permission for its Harley Street site remains very much on track for 2016, while planning for the Pebble Mill site is taking shape, and financing for this development is now in place. Having entered in an industrialisation agreement with Thales, AVO announced the agreement for a £24m loan from Metric Capital